🇺🇸 FDA

Intelligence · Clinical Pipeline

Oncology R&D Pipeline

Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Programs
5,568

Quick answer

Oncology: NovaPharmaNews indexes 5,568 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Top sponsors

Page 92 of 116

  1. CFT8634

    C4 Therapeutics

    Synovial Sarcoma

    phase 1 small molecule terminated

    1 trial

  2. CG-806

    Aptose Biosciences

    Chronic Lymphocytic Leukemia

    phase 1 small molecule terminated

    1 trial

  3. CG-806

    Aptose Biosciences

    Acute Myeloid Leukemia

    phase 1 small molecule terminated

    1 trial

  4. CG0070

    CG Oncology

    Muscle-Invasive Bladder Carcinoma

    phase 1 small molecule completed

    1 trial

  5. CGT4255

    Cogent Biosciences

    Advanced Solid Tumor, Adult

    phase 1 small molecule active

    1 trial

  6. CHR-2797 (tosedostat)

    United Therapeutics Europe Ltd

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  7. CHS-006 (anti-TIGIT)

    Coherus Oncology

    Advanced Solid Tumor

    phase 1 small molecule terminated

    1 trial

  8. CHS-1000

    Coherus Oncology

    Advanced or Metastatic Solid Tumors

    phase 1 mab active

    1 trial

  9. CHS-114

    Coherus Oncology

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  10. CHS-114

    Coherus Oncology

    Metastatic Solid Tumor

    phase 1 small molecule active

    1 trial

  11. CHS-388

    Coherus Oncology

    Advanced Solid Tumor

    phase 1 small molecule completed

    1 trial

  12. CITY

    Pari Pharma GmbH

    Cutaneous T-cell lymphomas (CTCL)

    phase 1 other active

    1 trial

  13. CLADRIBINE DOSE ESCALATION IN CONDITIONING REGIMEN PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (Allo-HSCT) FOR REFRACTORY ACUTE LEUKEMIA AND MYELODYSPLASTIC SYNDROMES

    The George Institute

    Acute leukemia and myelodysplastic syndromes

    phase 1 other active

    1 trial

  14. CLEVER PEPTIDE : Open-label, non-controlled, multicenter, dose escalation, first-in-human clinical trial to evaluate the safety, pharmacokinetics and preliminary antitumor activity of intravenous PEP-010, administered as single agent and in combination with paclitaxel or with gemcitabine in patients with recurrent and/or metastatic solid cancer

    The George Institute

    Patients with recurrent and/or metastatic solid cancer.

    phase 1 other active

    1 trial

  15. CLL1 and CD38 Dual-Target CAR-T Cell Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Myeloid Leukemia

    phase 1 small molecule active

    1 trial

  16. CLN-049

    Cullinan Therapeutics

    Relapsed/Refractory Acute Myeloid Leukemia (AML)

    phase 1 small molecule active

    1 trial

  17. CLN-617

    Cullinan Therapeutics

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  18. CLN-619

    Cullinan Therapeutics

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  19. CLR 131

    Cellectar Biosciences

    Head and Neck Cancer

    phase 1 small molecule completed

    1 trial

  20. CLR 131

    Cellectar Biosciences

    Pediatric Solid Tumor

    phase 1 small molecule active

    1 trial

  21. CMP-001

    Regeneron UK Limited

    Malignant Melanoma

    phase 1 small molecule completed

    1 trial

  22. CMP-001

    Regeneron UK Limited

    Non Small Cell Lung Cancer

    phase 1 small molecule completed

    1 trial

  23. CPI-006

    Corvus Pharmaceuticals

    Non-Small Cell Lung Cancer

    phase 1 small molecule completed

    1 trial

  24. CPI-818

    Corvus Pharmaceuticals

    T-cell Lymphoma

    phase 1 small molecule active

    1 trial

  25. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    Acute Myelogenous Leukemia

    phase 1 small molecule completed

    1 trial

  26. CPX-351 (Cytarabine:Daunorubicin) Liposome Injection

    Jazz Pharmaceuticals Ireland Limited

    Hematologic Neoplasms

    phase 1 small molecule completed

    1 trial

  27. CT-202

    Context Therapeutics

    Triple Negative Breast Cancer (TNBC)

    phase 1 small molecule active

    1 trial

  28. CT-95

    Context Therapeutics

    Mesothelin-Expressing Tumors

    phase 1 small molecule active

    1 trial

  29. CT053PTSA

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acute Myeloid Leukemia (AML)

    phase 1 small molecule terminated

    1 trial

  30. CT053PTSA

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  31. CTA101

    The First People's Hospital of Lianyungang

    Diffuse Large B-cell Lymphoma

    phase 1 mab active

    1 trial

  32. CTIM-76

    Context Therapeutics

    Platinum-resistant Ovarian Cancer

    phase 1 small molecule active

    1 trial

  33. CTX-10726

    Compass Therapeutics

    Gastroesophageal Cancer (GC)

    phase 1 small molecule active

    1 trial

  34. CTX-471

    Compass Therapeutics

    Locally Advanced Solid Tumor

    phase 1 small molecule completed

    1 trial

  35. CTX-8371

    Compass Therapeutics

    Non Small Cell Lung Cancer

    phase 1 small molecule active

    1 trial

  36. CTX130

    S.A.

    T Cell Lymphoma

    phase 1 mab terminated

    1 trial

  37. CTX130

    S.A.

    Renal Cell Carcinoma

    phase 1 mab terminated

    1 trial

  38. CUE-101

    Cue Biopharma

    Head and Neck Cancer

    phase 1 small molecule completed

    1 trial

  39. CUE-102

    Cue Biopharma

    Colorectal Cancer

    phase 1 small molecule completed

    1 trial

  40. CVA

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 1 small molecule active

    1 trial

  41. CX-188

    CytomX Therapeutics

    Solid Tumor, Adult

    phase 1 small molecule terminated

    1 trial

  42. CX-2051

    CytomX Therapeutics

    Solid Tumor, Adult

    phase 1 small molecule active

    1 trial

  43. CX-801

    CytomX Therapeutics

    Solid Tumor, Adult

    phase 1 small molecule active

    1 trial

  44. CX-904

    CytomX Therapeutics

    Solid Tumors

    phase 1 small molecule terminated

    1 trial

  45. CXD101

    United Therapeutics Europe Ltd

    Advanced Cancer

    phase 1 small molecule completed

    1 trial

  46. CY-219 CAR-T

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed/Refractory B-cell Lymphoma

    phase 1 small molecule active

    1 trial

  47. Cabiralizumab

    Prime Medicine

    Advanced Solid Tumors

    phase 1 mab completed

    1 trial

  48. Camidanlumab tesirine

    ADC Therapeutics SA

    Hodgkin Lymphoma

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many oncology pipeline programs are tracked?

5,568 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.